Sclerostin Antibody Treatment Stimulates Bone Formation to Normalize Bone Mass in Male Down Syndrome Mice

about

Sclerostin Antibody Treatment Stimulates Bone Formation to Normalize Bone Mass in Male Down Syndrome Mice

Item

http://www.wikidata.org/entity/Q57150920

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в січні 2018

@uk

name

Sclerostin Antibody Treatment ...... ass in Male Down Syndrome Mice

@en

Sclerostin Antibody Treatment ...... ass in Male Down Syndrome Mice

@nl

type

Item

label

Sclerostin Antibody Treatment ...... ass in Male Down Syndrome Mice

@en

Sclerostin Antibody Treatment ...... ass in Male Down Syndrome Mice

@nl

prefLabel

Sclerostin Antibody Treatment ...... ass in Male Down Syndrome Mice

@en

Sclerostin Antibody Treatment ...... ass in Male Down Syndrome Mice

@nl

P1476

Sclerostin Antibody Treatment ...... ass in Male Down Syndrome Mice

@en

P2093

Dana Gaddy

http://www.w3.org/2001/XMLSchema#string

Diarra K Williams

http://www.w3.org/2001/XMLSchema#string

Eric Schryver

http://www.w3.org/2001/XMLSchema#string

Francis L Swain

http://www.w3.org/2001/XMLSchema#string

Jami Schmidt

http://www.w3.org/2001/XMLSchema#string

Jessica Webber

http://www.w3.org/2001/XMLSchema#string

Larry J Suva

http://www.w3.org/2001/XMLSchema#string

Nisreen S Akel

http://www.w3.org/2001/XMLSchema#string

R Shane Shelton

http://www.w3.org/2001/XMLSchema#string

Sean G Parham

http://www.w3.org/2001/XMLSchema#string

P2860

Physiological role of mGSTA4-4, a glutathione S-transferase metabolizing 4-hydroxynonenal: generation and analysis of mGsta4 null mouse

Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis

Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment

Characteristics of adults with down syndrome: prevalence of age-related conditions

Bone mineral mass in males and females with and without Down syndrome.

Maternal age specific risk rate estimates for Down syndrome among live births in whites and other races from Ohio and metropolitan Atlanta, 1970-1989

Suppression of Sclerostin Alleviates Radiation-Induced Bone Loss by Protecting Bone-Forming Cells and Their Progenitors Through Distinct Mechanisms.

Sclerostin antibody inhibits skeletal deterioration due to reduced mechanical loading

Inhibiting the osteocyte-specific protein sclerostin increases bone mass and fracture resistance in multiple myeloma

Aneuploidy and skeletal health.

P304

47-54

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JBM4.10025

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30283889

http://www.w3.org/2001/XMLSchema#string

P932

6124205

http://www.w3.org/2001/XMLSchema#string